Symbols / BRIA $1.57 +1.29% BrilliA Inc
BRIA Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteBrilliA Inc designs, manufactures, and sells ladies intimate apparel in North America, the European Union, the Asia Pacific, Latin America, the Middle East, and internationally. The company's products include active, shape, sleep, baby, and swim wear; bra and panties; lingerie; brassiere; bodysuits; dresses; tops; and other products under DIANA, Vanity Fair, Hanes, Wonderbra, Playtex, Bali, Maidenform, Jockey, Lands' End, fleur du mal, Kiki de Montparnasse, and Bra n Things brands. It sells through website, social media, and marketplace platforms like Shopee. The company was incorporated in 2023 and is based in Singapore.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-08-29 | init | Alliance Global Partners | — → Buy | $5 |
- Cancer biotech BriaCell raises $4.7M in share sale - Stock Titan ue, 02 Jun 2026 20
- DSMB Recommends Continuation of Bria-IMT Investigation in Metastatic Breast Cancer - OncLive ue, 26 May 2026 23
- Cancer immunotherapy firm BriaCell raises $4.7M for operations - Stock Titan Sun, 31 May 2026 23
- TLC’s ‘Unpolished’ Star Bria Mancuso Shares First Photos of Newborn Son Matthew: ‘Unexpected Gift’ (Exclusive) - Yahoo Fri, 10 Apr 2026 07
- BriaCell Stock Notches Best Day In 5 Years On Breast Cancer Data — Then Drops 10% After-Hours: What Went Wrong? - Stocktwits Wed, 14 Jan 2026 05
- BriaCell stock notches best day in 5 years on breast cancer data — then drops 10% after-hours: What went wrong? - MSN Wed, 14 Jan 2026 06
- BCTXW Stock Price, Quote & Chart | BRIACELL THERAPEUTICS -CW27 (NASDAQ:BCTXW) - ChartMill hu, 26 Feb 2026 08
- BrilliA builds Indonesia supply chain as brands look beyond China - Stock Titan Mon, 11 May 2026 07
- Breast cancer vaccine Bria-IMT shows 16.6-month survival, home-use potential - Stock Titan Fri, 22 May 2026 07
- New prostate cancer immunotherapy from BriaCell planned for Phase 1/2a trial - Stock Titan hu, 14 May 2026 07
- Breast cancer trial that could bring new therapy closer passes 230 patients - Stock Titan ue, 12 May 2026 07
- Pivotal breast cancer trial brings Penn Medicine into BriaCell study - Stock Titan Wed, 13 May 2026 07
- FDA clears BriaCell's personalized breast cancer study to start - Stock Titan Wed, 06 May 2026 07
- BrilliA (BRIA) director submits initial Form 3 insider ownership filing - Stock Titan Wed, 25 Mar 2026 07
- BrilliA Inc (NASDAQ: BRIA) director files Form 3 initial ownership - Stock Titan hu, 26 Mar 2026 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
64.39
+15.06%
|
55.96
+5.74%
|
52.93
-25.37%
|
70.92
|
| Operating Revenue |
|
64.39
+15.06%
|
55.96
+5.74%
|
52.93
-25.37%
|
70.92
|
| Cost Of Revenue |
|
53.96
+14.02%
|
47.32
+8.06%
|
43.79
-28.25%
|
61.03
|
| Reconciled Cost Of Revenue |
|
53.96
+14.02%
|
47.32
+8.06%
|
43.79
-28.51%
|
61.26
|
| Gross Profit |
|
10.43
+20.73%
|
8.64
-5.41%
|
9.13
-7.61%
|
9.89
|
| Operating Expense |
|
6.37
+53.98%
|
4.14
+12.85%
|
3.67
-8.87%
|
4.02
|
| Selling General And Administration |
|
4.19
+42.72%
|
2.94
+7.54%
|
2.73
+19.03%
|
2.30
|
| Selling And Marketing Expense |
|
0.02
+400.00%
|
0.00
+0.00%
|
0.00
|
—
|
| General And Administrative Expense |
|
4.17
+42.23%
|
2.93
+7.55%
|
2.73
+18.85%
|
2.30
|
| Salaries And Wages |
|
3.37
+46.97%
|
2.29
+2.14%
|
2.25
-2.10%
|
2.30
|
| Other Gand A |
|
0.61
+99.02%
|
0.31
+56.92%
|
0.20
|
—
|
| Other Operating Expenses |
|
1.31
+104.54%
|
0.64
+30.14%
|
0.49
-67.39%
|
1.51
|
| Total Expenses |
|
60.33
+17.23%
|
51.46
+8.43%
|
47.46
-27.05%
|
65.06
|
| Operating Income |
|
4.06
-9.82%
|
4.50
-17.65%
|
5.47
-6.75%
|
5.86
|
| EBITDA |
|
4.58
+0.07%
|
4.58
-19.37%
|
5.67
-6.42%
|
6.06
|
| Normalized EBITDA |
|
4.65
-2.72%
|
4.78
-15.32%
|
5.65
-7.27%
|
6.09
|
| Reconciled Depreciation |
|
0.46
+130.65%
|
0.20
-7.44%
|
0.21
+65850.92%
|
0.00
|
| EBIT |
|
4.12
-5.87%
|
4.38
-19.84%
|
5.46
-6.54%
|
5.84
|
| Total Unusual Items |
|
-0.07
+64.56%
|
-0.21
-835.71%
|
0.03
+211.31%
|
-0.03
|
| Total Unusual Items Excluding Goodwill |
|
-0.07
+64.56%
|
-0.21
-835.71%
|
0.03
+211.31%
|
-0.03
|
| Special Income Charges |
|
-0.00
+98.31%
|
-0.24
-1211.11%
|
-0.02
+28.45%
|
-0.03
|
| Write Off |
|
0.00
-98.31%
|
0.24
+1211.11%
|
0.02
-28.45%
|
0.03
|
| Net Income |
|
2.82
-14.20%
|
3.28
-24.64%
|
4.35
-8.96%
|
4.78
|
| Pretax Income |
|
3.62
-9.28%
|
3.99
-23.93%
|
5.24
-9.41%
|
5.79
|
| Net Non Operating Interest Income Expense |
|
-0.36
-13.04%
|
-0.32
-25.78%
|
-0.26
-389.85%
|
-0.05
|
| Interest Expense Non Operating |
|
0.50
+29.20%
|
0.39
+80.00%
|
0.21
+311.40%
|
0.05
|
| Net Interest Income |
|
-0.36
-13.04%
|
-0.32
-25.78%
|
-0.26
-389.85%
|
-0.05
|
| Interest Expense |
|
0.50
+29.20%
|
0.39
+80.00%
|
0.21
+311.40%
|
0.05
|
| Interest Income Non Operating |
|
0.18
+74.53%
|
0.11
+1666.67%
|
0.01
|
—
|
| Interest Income |
|
0.18
+74.53%
|
0.11
+1666.67%
|
0.01
|
—
|
| Other Income Expense |
|
-0.08
+59.38%
|
-0.19
-700.00%
|
0.03
+243.85%
|
-0.02
|
| Other Non Operating Income Expenses |
|
-0.01
-135.71%
|
0.01
+250.00%
|
0.00
+37.46%
|
0.00
|
| Gain On Sale Of Security |
|
-0.07
-330.00%
|
0.03
-34.78%
|
0.05
|
—
|
| Tax Provision |
|
0.80
+13.48%
|
0.70
-20.34%
|
0.89
-11.68%
|
1.00
|
| Tax Rate For Calcs |
|
0.00
+25.08%
|
0.00
+4.72%
|
0.00
-2.50%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.02
+55.68%
|
-0.04
-870.47%
|
0.00
+208.52%
|
-0.00
|
| Net Income Including Noncontrolling Interests |
|
2.82
-14.16%
|
3.28
-24.66%
|
4.36
-8.94%
|
4.79
|
| Net Income From Continuing Operation Net Minority Interest |
|
2.82
-14.20%
|
3.28
-24.64%
|
4.35
-8.96%
|
4.78
|
| Net Income From Continuing And Discontinued Operation |
|
2.82
-14.20%
|
3.28
-24.64%
|
4.35
-8.96%
|
4.78
|
| Net Income Continuous Operations |
|
2.82
-14.16%
|
3.28
-24.66%
|
4.36
-8.94%
|
4.79
|
| Minority Interests |
|
-0.00
-33.33%
|
-0.00
+40.00%
|
-0.01
-13.92%
|
-0.00
|
| Normalized Income |
|
2.87
-16.77%
|
3.45
-20.32%
|
4.33
-9.84%
|
4.80
|
| Net Income Common Stockholders |
|
2.82
-14.20%
|
3.28
-24.64%
|
4.35
-8.96%
|
4.78
|
| Diluted EPS |
|
0.12
-20.00%
|
0.15
-21.05%
|
0.19
-20.83%
|
0.24
|
| Basic EPS |
|
0.12
-20.00%
|
0.15
-21.05%
|
0.19
-20.83%
|
0.24
|
| Basic Average Shares |
|
23.34
+3.74%
|
22.50
+0.00%
|
22.50
+12.50%
|
20.00
|
| Diluted Average Shares |
|
23.34
+3.74%
|
22.50
+0.00%
|
22.50
+12.50%
|
20.00
|
| Diluted NI Availto Com Stockholders |
|
2.82
-14.20%
|
3.28
-24.64%
|
4.35
-8.96%
|
4.78
|
| Depreciation Amortization Depletion Income Statement |
|
0.46
+130.65%
|
0.20
-7.44%
|
0.21
-3.16%
|
0.22
|
| Depreciation And Amortization In Income Statement |
|
0.46
+130.65%
|
0.20
-7.44%
|
0.21
-3.16%
|
0.22
|
| Depreciation Income Statement |
|
0.46
+130.65%
|
0.20
-7.44%
|
0.21
-3.16%
|
0.22
|
| Insurance And Claims |
|
0.13
+0.00%
|
0.13
+23.58%
|
0.11
|
—
|
| Other Taxes |
|
0.41
+13.85%
|
0.36
+58.33%
|
0.23
|
—
|
| Rent And Landing Fees |
|
0.06
-70.30%
|
0.20
+12.22%
|
0.18
|
—
|
| Rent Expense Supplemental |
|
0.06
-70.30%
|
0.20
+12.22%
|
0.18
|
—
|
| Total Other Finance Cost |
|
0.05
+19.51%
|
0.04
-12.77%
|
0.05
|
—
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets |
|
28.41
+4.63%
|
27.15
+22.28%
|
22.20
-10.92%
|
24.93
|
| Current Assets |
|
25.69
-1.94%
|
26.20
+18.01%
|
22.20
-10.92%
|
24.92
|
| Cash Cash Equivalents And Short Term Investments |
|
7.70
+20.66%
|
6.38
-28.37%
|
8.91
+104.40%
|
4.36
|
| Cash And Cash Equivalents |
|
7.70
+20.66%
|
6.38
-28.37%
|
8.91
+104.40%
|
4.36
|
| Cash Equivalents |
|
6.10
|
—
|
—
|
—
|
| Cash Financial |
|
1.61
|
—
|
8.91
+104.40%
|
4.36
|
| Receivables |
|
7.88
+10.31%
|
7.14
+194.46%
|
2.43
-60.96%
|
6.21
|
| Accounts Receivable |
|
7.55
+14.52%
|
6.59
+183.51%
|
2.33
-62.57%
|
6.21
|
| Gross Accounts Receivable |
|
7.83
+13.98%
|
6.87
+190.17%
|
2.37
-62.04%
|
6.24
|
| Allowance For Doubtful Accounts Receivable |
|
-0.28
-1.43%
|
-0.28
-551.47%
|
-0.04
-70.24%
|
-0.03
|
| Other Receivables |
|
0.03
-16.13%
|
0.03
|
—
|
—
|
| Taxes Receivable |
|
0.07
+13.56%
|
0.06
|
—
|
—
|
| Inventory |
|
7.28
+2.64%
|
7.09
+23.76%
|
5.73
-41.12%
|
9.74
|
| Raw Materials |
|
3.17
-1.51%
|
3.22
+23.03%
|
2.61
-39.85%
|
4.35
|
| Work In Process |
|
1.57
+54.78%
|
1.02
+61.76%
|
0.63
-47.66%
|
1.20
|
| Finished Goods |
|
2.54
-11.18%
|
2.86
+14.95%
|
2.49
-40.58%
|
4.19
|
| Prepaid Assets |
|
2.83
-49.28%
|
5.58
+8.75%
|
5.13
+11.23%
|
4.61
|
| Total Non Current Assets |
|
2.72
+185.29%
|
0.95
+26162.07%
|
0.00
-26.60%
|
0.00
|
| Net PPE |
|
1.72
+1392.17%
|
0.12
+3072.41%
|
0.00
-26.60%
|
0.00
|
| Gross PPE |
|
2.36
+628.40%
|
0.32
+4463.38%
|
0.01
+0.00%
|
0.01
|
| Accumulated Depreciation |
|
-0.64
-208.13%
|
-0.21
-5914.39%
|
-0.00
-60.81%
|
-0.00
|
| Properties |
|
0.00
|
0.00
|
—
|
—
|
| Buildings And Improvements |
|
1.98
|
0.00
|
—
|
—
|
| Machinery Furniture Equipment |
|
0.38
+17.59%
|
0.32
+4463.38%
|
0.01
+0.00%
|
0.01
|
| Other Properties |
|
—
|
0.12
|
—
|
—
|
| Investments And Advances |
|
1.00
|
0.00
|
—
|
—
|
| Non Current Deferred Assets |
|
0.00
-100.00%
|
0.84
|
0.00
|
—
|
| Total Liabilities Net Minority Interest |
|
10.33
-45.75%
|
19.05
+21.28%
|
15.71
-3.65%
|
16.30
|
| Current Liabilities |
|
9.04
-52.57%
|
19.05
+21.28%
|
15.71
-3.65%
|
16.30
|
| Payables And Accrued Expenses |
|
8.65
-54.57%
|
19.05
+21.28%
|
15.71
-3.65%
|
16.30
|
| Payables |
|
7.25
-59.03%
|
17.70
+25.83%
|
14.06
-0.99%
|
14.20
|
| Accounts Payable |
|
3.29
-56.84%
|
7.62
+45.05%
|
5.26
-46.34%
|
9.79
|
| Other Payable |
|
0.51
-93.39%
|
7.65
+7.53%
|
7.12
+106.18%
|
3.45
|
| Current Accrued Expenses |
|
1.40
+3.70%
|
1.35
-17.67%
|
1.64
-21.67%
|
2.10
|
| Total Tax Payable |
|
3.27
+38.55%
|
2.36
+40.38%
|
1.68
+96.03%
|
0.86
|
| Income Tax Payable |
|
3.08
+33.62%
|
2.31
+36.94%
|
1.68
+96.03%
|
0.86
|
| Current Debt And Capital Lease Obligation |
|
0.38
|
—
|
—
|
—
|
| Current Capital Lease Obligation |
|
0.38
|
0.00
|
—
|
—
|
| Other Current Liabilities |
|
—
|
-0.00
|
—
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
1.30
|
0.00
|
0.00
|
0.00
|
| Long Term Debt And Capital Lease Obligation |
|
1.30
|
0.00
|
—
|
—
|
| Long Term Capital Lease Obligation |
|
1.30
|
0.00
|
—
|
—
|
| Stockholders Equity |
|
18.06
+123.16%
|
8.09
+24.52%
|
6.50
-24.66%
|
8.63
|
| Common Stock Equity |
|
18.06
+123.16%
|
8.09
+24.52%
|
6.50
-24.66%
|
8.63
|
| Capital Stock |
|
13.85
+107.90%
|
6.66
+6660900.00%
|
0.00
+0.00%
|
0.00
|
| Common Stock |
|
13.85
+107.90%
|
6.66
+6660900.00%
|
0.00
+0.00%
|
0.00
|
| Share Issued |
|
25.00
+0.00%
|
25.00
+0.00%
|
25.00
+0.00%
|
25.00
|
| Ordinary Shares Number |
|
25.00
+0.00%
|
25.00
+0.00%
|
25.00
+0.00%
|
25.00
|
| Retained Earnings |
|
10.30
+37.59%
|
7.49
+15.23%
|
6.50
-24.66%
|
8.63
|
| Gains Losses Not Affecting Retained Earnings |
|
-6.09
-0.59%
|
-6.06
|
—
|
—
|
| Minority Interest |
|
0.02
+33.33%
|
0.01
|
—
|
—
|
| Other Equity Adjustments |
|
-5.91
+0.00%
|
-5.91
|
—
|
—
|
| Total Equity Gross Minority Interest |
|
18.07
+123.03%
|
8.10
+24.71%
|
6.50
-24.66%
|
8.63
|
| Total Capitalization |
|
18.06
+123.16%
|
8.09
+24.52%
|
6.50
-24.66%
|
8.63
|
| Working Capital |
|
16.66
+132.90%
|
7.15
+10.12%
|
6.49
-24.66%
|
8.62
|
| Invested Capital |
|
18.06
+123.16%
|
8.09
+24.52%
|
6.50
-24.66%
|
8.63
|
| Total Debt |
|
1.68
|
0.00
|
—
|
—
|
| Capital Lease Obligations |
|
1.68
|
0.00
|
—
|
—
|
| Net Tangible Assets |
|
18.06
+123.16%
|
8.09
+24.52%
|
6.50
-24.66%
|
8.63
|
| Tangible Book Value |
|
18.06
+123.16%
|
8.09
+24.52%
|
6.50
-24.66%
|
8.63
|
| Duefrom Related Parties Current |
|
0.23
-48.80%
|
0.46
+359.00%
|
0.10
|
0.00
|
| Dueto Related Parties Current |
|
0.18
+215.79%
|
0.06
+597.59%
|
0.01
-91.79%
|
0.10
|
| Financial Assets Designatedas Fair Value Through Profitor Loss Total |
|
1.00
|
0.00
|
—
|
—
|
| Foreign Currency Translation Adjustments |
|
-0.18
-25.00%
|
-0.14
|
—
|
—
|
| Investmentin Financial Assets |
|
1.00
|
0.00
|
—
|
—
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-4.52
-3238.89%
|
0.14
-98.70%
|
11.08
+208.38%
|
3.59
|
| Cash Flow From Continuing Operating Activities |
|
-4.52
-3238.89%
|
0.14
-98.70%
|
11.08
+208.38%
|
3.59
|
| Net Income From Continuing Operations |
|
3.62
-9.28%
|
3.99
-23.93%
|
5.24
+0.77%
|
5.20
|
| Depreciation Amortization Depletion |
|
0.46
+130.65%
|
0.20
-7.44%
|
0.21
+65850.92%
|
0.00
|
| Depreciation |
|
0.46
+130.65%
|
0.20
-7.44%
|
0.21
+65850.92%
|
0.00
|
| Depreciation And Amortization |
|
0.46
+130.65%
|
0.20
-7.44%
|
0.21
+65850.92%
|
0.00
|
| Other Non Cash Items |
|
-0.07
+28.87%
|
-0.10
-488.00%
|
0.03
|
—
|
| Asset Impairment Charge |
|
0.00
-98.31%
|
0.24
+1211.11%
|
0.02
-28.45%
|
0.03
|
| Change In Working Capital |
|
-8.50
-113.30%
|
-3.98
-169.90%
|
5.70
+448.27%
|
-1.64
|
| Change In Receivables |
|
2.02
+139.06%
|
-5.17
-260.02%
|
3.23
+182.47%
|
-3.92
|
| Change In Inventory |
|
-0.19
+86.27%
|
-1.36
-134.02%
|
4.00
+1078.55%
|
0.34
|
| Change In Payables And Accrued Expense |
|
-11.17
-430.32%
|
3.38
+320.84%
|
-1.53
-178.98%
|
1.94
|
| Change In Payable |
|
-11.17
-430.32%
|
3.38
+320.84%
|
-1.53
-178.98%
|
1.94
|
| Change In Other Working Capital |
|
0.84
+200.00%
|
-0.84
|
—
|
—
|
| Investing Cash Flow |
|
-0.89
-1910.20%
|
0.05
+1733.33%
|
-0.00
+38.63%
|
-0.00
|
| Cash Flow From Continuing Investing Activities |
|
-0.89
-1910.20%
|
0.05
+1733.33%
|
-0.00
+38.63%
|
-0.00
|
| Net PPE Purchase And Sale |
|
-0.07
-26.32%
|
-0.06
-533.33%
|
-0.01
-84.12%
|
-0.00
|
| Purchase Of PPE |
|
-0.07
-26.32%
|
-0.06
-533.33%
|
-0.01
-84.12%
|
-0.00
|
| Capital Expenditure |
|
-0.07
-26.32%
|
-0.06
-533.33%
|
-0.01
-84.12%
|
-0.00
|
| Net Investment Purchase And Sale |
|
-1.00
|
0.00
|
0.00
|
—
|
| Purchase Of Investment |
|
-1.00
|
0.00
|
0.00
|
—
|
| Financing Cash Flow |
|
6.71
+343.93%
|
-2.75
+60.08%
|
-6.89
-38.46%
|
-4.97
|
| Cash Flow From Continuing Financing Activities |
|
6.71
+343.93%
|
-2.75
+60.08%
|
-6.89
-38.46%
|
-4.97
|
| Net Issuance Payments Of Debt |
|
-0.36
-78.71%
|
-0.20
+1.94%
|
-0.21
|
—
|
| Repayment Of Debt |
|
-0.36
-78.71%
|
-0.20
+1.94%
|
-0.21
|
—
|
| Long Term Debt Payments |
|
-0.36
-78.71%
|
-0.20
+1.94%
|
-0.21
|
—
|
| Net Long Term Debt Issuance |
|
-0.36
-78.71%
|
-0.20
+1.94%
|
-0.21
|
—
|
| Net Common Stock Issuance |
|
7.19
|
0.00
|
0.00
|
—
|
| Common Stock Dividend Paid |
|
0.00
+100.00%
|
-3.15
+49.98%
|
-6.30
-384.62%
|
-1.30
|
| Cash Dividends Paid |
|
0.00
+100.00%
|
-3.15
+49.98%
|
-6.30
-384.62%
|
-1.30
|
| Net Other Financing Charges |
|
-0.00
-100.33%
|
0.61
+274.36%
|
-0.35
+90.45%
|
-3.67
|
| Changes In Cash |
|
1.30
+150.88%
|
-2.56
-161.06%
|
4.19
+401.97%
|
-1.39
|
| Effect Of Exchange Rate Changes |
|
0.02
+116.98%
|
-0.11
-178.95%
|
-0.04
|
—
|
| Beginning Cash Position |
|
6.38
-29.44%
|
9.05
+84.75%
|
4.90
-14.80%
|
5.75
|
| End Cash Position |
|
7.70
+20.66%
|
6.38
-29.44%
|
9.05
+107.48%
|
4.36
|
| Free Cash Flow |
|
-4.59
-5378.16%
|
0.09
-99.21%
|
11.07
+208.54%
|
3.59
|
| Common Stock Issuance |
|
7.19
|
0.00
|
0.00
|
—
|
| Interest Paid CFF |
|
-0.12
-1188.89%
|
-0.01
+70.97%
|
-0.03
|
—
|
| Interest Received CFI |
|
0.18
+74.53%
|
0.11
+1666.67%
|
0.01
|
—
|
| Issuance Of Capital Stock |
|
7.19
|
0.00
|
0.00
|
—
|
| Taxes Refund Paid |
|
-0.03
+83.33%
|
-0.20
-59.68%
|
-0.12
|
—
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|